Split History
BBH split history picture
VanEck Vectors ETF Trust - Biotech ETF (BBH) has 1 split in our BBH split history database. The split for BBH took place on February 14, 2012. This was a 3 for 1 split, meaning for each share of BBH owned pre-split, the shareholder now owned 3 shares. For example, a 1000 share position pre-split, became a 3000 share position following the split.

When a company such as VanEck Vectors ETF Trust - Biotech ETF splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.

Looking at the BBH split history from start to finish, an original position size of 1000 shares would have turned into 3000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into VanEck Vectors ETF Trust - Biotech ETF shares, starting with a $10,000 purchase of BBH, presented on a split-history-adjusted basis factoring in the complete BBH split history. BBH split adjusted history picture

Growth of $10,000.00
With Dividends Reinvested

Start date: 04/09/2010
End date: 04/08/2020
Start price/share: $34.78
End price/share: $134.94
Starting shares: 287.52
Ending shares: 325.80
Dividends reinvested/share: $6.25
Total return: 339.64%
Average Annual Total Return: 15.95%
Starting investment: $10,000.00
Ending investment: $43,960.20
Years: 10.01
Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/09/2010
End date: 04/08/2020
Start price/share: $34.78
End price/share: $134.94
Dividends collected/share: $6.25
Total return: 305.94%
Average Annual Total Return: 15.03%
Starting investment: $10,000.00
Ending investment: $40,592.37
Years: 10.01
Market Vectors Biotech ETF is an open-end management investment company. The Fund seeks to replicate the price and yield performance of the Market Vectors U.S. Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the benchmark index. The Biotech Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include small- and medium-capitalization companies and foreign companies that are listed on a U.S. exchange. As of Sept 30 2013, the Fund's total assets were $435,917,620 and its investment portfolio was valued at $434,447,714. According to our BBH split history records, VanEck Vectors ETF Trust - Biotech ETF has had 1 split.
Date Ratio
02/14/20123 for 1
BBH is categorized under the Financials sector; below are some other companies in the same sector that also have a history of stock splits:

BBRC Split History
BBT Split History
BBVA Split History
BCA Split History
BCBP Split History
BCF Split History
BCH Split History
BCS Split History
BCTF Split History
BDGE Split History

Also explore: BBH shares outstanding history

Chanticleer Holdings, Inc. (BURG)
Ekso Bionics Holdings, Inc. (EKSO)
Mid-Con Energy Partners, LP (MCEP)
U.S. Gold Corp. (USAU)
Direxion Daily Latin America Bull 3X Shares (LBJ)
Direxion Daily MSCI Mexico Bull 3X Shares (MEXX)
Direxion Daily Natural Gas Related Bear 3X Shares (GASX)
Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3X Shares (DRIP)
SUMR Brands (SUMR)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

BBH Split History | www.SplitHistory.com | Copyright © 2013 - 2020, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.